4//SEC Filing
Equels Thomas K 4
Accession 0001641172-25-005861
CIK 0000946644other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 4:35 PM ET
Size
5.0 KB
Accession
0001641172-25-005861
Insider Transaction Report
Form 4
Equels Thomas K.
Director
Transactions
- Purchase
Common Stock
2025-04-11$0.03/sh+1,968,504$50,000→ 3,867,533 total
Footnotes (1)
- [F1]Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.
Documents
Issuer
AIM ImmunoTech Inc.
CIK 0000946644
Entity typeother
Related Parties
1- filerCIK 0001450324
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 4:35 PM ET
- Size
- 5.0 KB